Oct 3 (Reuters) - DRI Healthcare Trust:
* DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF PAYMENT
STREAMS
BASED ON THE CAS9 GENE-EDITING TECHNOLOGY FOR CASGEVY®
(EXAGAMGLOGENE AUTOTEMCEL)
* DRI HEALTHCARE TRUST - ACQUIRES PAYMENT RIGHTS FOR CASGEVY
FOR
$57 MILLION
* DRI HEALTHCARE TRUST - TO RECEIVE MID-DOUBLE-DIGIT
PERCENTAGE OF
$50 MILLION CONTINGENT PAYMENT
Source text for Eikon:
Further company coverage: